Investors
Since its foundation in 1997, Probiodrug has managed to attract a selected group of renowned investors and has raised a total of appr. $71 million in private equity.
The Company´s key investors are:
BB Biotech
Edmond de Rothschild Investment Partners
Life Sciences Partners
Biogen Idec New Ventures
TVM Capital
HBM BioVentures
Goodvent Beteiligungsmanagement GmbH & Co. KG
CFH GmbH - LBBW Group
Tbg Technologie-Beteiligungs-Gesellschaft (now: KfW Mittelstandsbank)
Wellington Management
Bayern Kapital GmbH